Arndt P, Leger R, Garratty G. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests. Transfusion. 1999;39:1239-1246.
2.
Lascari AD, Amyot K. Fatal hemolysis caused by ceftriaxone. J Pediatr. 1995;126:816-817.
3.
Bernini JC, Mustafa MM, Sutor LJ, Buchanan GR. Fatal hemolysis induced by ceftriaxone in a child with sickle cell anemia. J Pediatr. 1995;126:814-816.
4.
Borgna-Pignatti C, Bezzi TM, Reverberi R. Fatal ceftriaxone-induced hemolysis in a child with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1995;14:1116-1117.
5.
Scimeca PG, Weinblatt ME, Boxer R. Hemolysis after treatment with ceftriaxone. J Pediatr. 1996;128:163.
6.
Moallem HJ, Garratty G, Wakeham M, et al.Ceftriaxone-related fatal hemolysis in an adolescent with perinatally acquired human immunodeficiency virus infection. J Pediatr. 1998;133:279-281.
7.
Meyer O, Hackstein H, Hoppe B, et al.Fatal immune haemolysis due to a degradation product of ceftriaxone. Br J Haematol. 1999;105:1084-1085.
8.
Viner Y, Hashkes P, Yakubova R, et al.Severe hemolysis induced by ceftriaxone in a child with sickle-cell anemia. Pediatr Infect Dis J. 2000;19:83-84.
9.
Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anemia associated with intravascular immune hemolysis. Transfusion. 1991;31:176-179.
10.
Longo F, Hastier P, Buckley M, et al.Acute hepatitis, autoimmune hemolytic anemia and erythroblastocytopenia induced by ceftriaxone. Am J Gastroenterol. 1998;93:836-837.
11.
Maraspin V, Lotric-Furlan S, Strle F. Ceftriaxone-associated hemolysis. Wien Klin Wochenschr. 1999;111:368-370.
12.
Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med. 2000;26:1390-1394.
13.
Falezza GC, Piccoli PL, Franchini M, et al.Ceftriaxone-induced hemolysis in an adult. Transfusion. 2000;40:1543-1544.
14.
Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis. 2002;8:112-128.
15.
Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Aliment Pharmacol Ther. 2001;15:1699-1708.
16.
Goldfinger D. Acute hemolytic transfusion reactions-a fresh look at pathogenesis and considerations regarding therapy. Transfusion. 1977;17:85-98.
17.
Brecher ME. Hemolytic transfusion reactions. In: Rossi EC, Simon TL, Moss GS, Gould SA, eds. Principles of Transfusion Medicine. Baltimore: Williams & Wilkins, 1996:747-763.
18.
Shirey RS, Bartholomew J, Bell W, et al.Characterization of antibody and selection of alternative drug therapy in hydrochlorothiazide-induced immune hemolytic anemia. Transfusion. 1989;28:70-72.
